Walleye Trading’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.5K Sell
50,600
-147,600
-74% -$304K ﹤0.01% 3512
2025
Q4
$392K Buy
198,200
+17,700
+10% +$56.7K ﹤0.01% 2983
2025
Q3
$525K Buy
180,500
+44,900
+33% +$103K ﹤0.01% 2711
2025
Q2
$245K Sell
135,600
-14,500
-10% -$25.8K ﹤0.01% 3110
2025
Q1
$225K Sell
150,100
-119,800
-44% -$302K ﹤0.01% 3019
2024
Q4
$637K Buy
269,900
+155,700
+136% +$2.73M ﹤0.01% 2454
2024
Q3
$3.36M Sell
114,200
-9,900
-8% -$228K 0.01% 1359
2024
Q2
$1.53M Buy
124,100
+2,800
+2% +$59K ﹤0.01% 1774
2024
Q1
$2.46M Sell
121,300
-40,800
-25% -$940K 0.01% 1607
2023
Q4
$3.65M Buy
162,100
+69,700
+75% +$1.47M 0.01% 1451
2023
Q3
$1.54M Buy
92,400
+78,600
+570% +$1.56M ﹤0.01% 1997
2023
Q2
$338K Buy
13,800
+6,600
+92% +$159K ﹤0.01% 3076
2023
Q1
$174K Buy
+7,200
New +$199K ﹤0.01% 3601
2022
Q4
Sell
-5,200
Closed -$217K 5360
2022
Q3
$217K Sell
5,200
-8,600
-62% -$232K ﹤0.01% 3607
2022
Q2
$388K Buy
+13,800
New +$349K ﹤0.01% 3148
2022
Q1
Sell
-8,200
Closed -$358K 5854
2021
Q4
$358K Sell
8,200
-11,200
-58% -$587K ﹤0.01% 3295
2021
Q3
$1.2M Buy
19,400
+19,100
+6,367% +$1.59M ﹤0.01% 2023
2021
Q2
$26K Sell
300
-4,700
-94% -$252K ﹤0.01% 4784
2021
Q1
$225K Buy
+5,000
New +$197K ﹤0.01% 3504

Other funds holding FLNA

Walleye Trading's FLNA Position: Q1 2026 in Review

Walleye Trading increased its Filana Therapeutics (FLNA) stake by 128% in Q1 2026, buying an estimated $24.3K and bringing the position to 20,968 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3759.

Walleye Trading first reported a position in FLNA in Q2 2016 and has held it in 9 quarters since. The position peaked at $662K in Q2 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Walleye Trading held 20,968 shares of Filana Therapeutics worth $35.4K as of Q1 2026.
  • Walleye Trading bought 11,790 Filana Therapeutics shares in Q1 2026, an estimated $24.3K.
  • Filana Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3759 holding.
  • Walleye Trading first reported a position in Filana Therapeutics in Q2 2016 and has held it in 9 quarters since.
  • Walleye Trading's Filana Therapeutics position peaked at $662K in Q2 2023.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.